MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Molecular Pharmacology Fast Forward
First published on November 7, 2007; DOI: 10.1124/mol.107.039875

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039875v1
mol.107.039875v2
73/2/518    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heitman, L.
Right arrow Articles by IJzerman, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heitman, L.
Right arrow Articles by IJzerman, A. P.


Received for publication July 11, 2007.
Revised November 7, 2007.
Accepted for publication November 7, 2007.

[3H]Org 43553, the First Low Molecular Weight Agonistic and Allosteric Radioligand for the Human Luteinizing Hormone Receptor

Laura Heitman 1, Julia Oosterom 2, Kimberly Bonger 3, Cornelis Timmers 2, Peter Wiegerinck 2, Ad P. IJzerman 4*

1 LACDR 2 NV Organon 3 LIC 4 Leiden University--LACDR

* Address correspondence to: E-mail: ijzerman{at}lacdr.leidenuniv.nl

Abstract

The luteinizing hormone (LH) receptor plays a pivotal role in reproduction. The high-molecular-weight (HMW) hCG and LH are the endogenous ligands of this receptor and bind to its large N-terminus. The present study characterizes the binding of a new low-molecular-weight (LMW) radioligand, [3H]Org 43553, at the LH receptor. Equilibrium saturation and displacement assays were developed and optimized. Specific binding of [3H]Org 43553 to CHO-K1 cell membranes expressing the human LH receptor and a CRE-luciferase reporter gene was saturable with a KD value of 2.4 ± 0.4 nM and a Bmax value of 1.6 ± 0.2 pmol/mg protein. Affinities of five LMW analogues of Org 43553 were determined. All displaced the radioligand competitively with Ki values ranging from 3.3 - 100 nM. Lastly, the potency of these compounds in a cAMP-induced luciferase assay was also determined. There was a high correlation between affinity and potency (r = 0.99; P < 0.0001) of these compounds. In the search for LMW ligands, which bind allosterically to the seven-transmembrane (7-TM) domain of the LH receptor, a HMW radioligand (e.g. [125I]hCG) is not suitable as it is not displaced by a LMW compound. Therefore, [3H]Org 43553, a new radioligand with good binding properties, allows screening for new LMW ligands that mimic the action of the endogenous hormone at the LH receptor.


Key words: Neuropeptides, Gonadotropins, Receptor binding studies


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk
The Mammalian Ovary from Genesis to Revelation
Endocr. Rev., October 1, 2009; 30(6): 624 - 712.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Neumann, W. Huang, S. Titus, G. Krause, G. Kleinau, A. T. Alberobello, W. Zheng, N. T. Southall, J. Inglese, C. P. Austin, et al.
Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice
PNAS, July 28, 2009; 106(30): 12471 - 12476.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics